Immune‐Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non‐Small Cell Lung Cancer

BACKGROUND: Although predictive value of immune‐related adverse events (irAEs) induced by immune checkpoint inhibitors (ICIs) have been suggested by several studies, their assessments were insufficient because patients were categorized only by the occurrence of irAEs. It has not been elucidated whet...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Akamatsu, Hiroaki, Murakami, Eriko, Oyanagi, Jun, Shibaki, Ryota, Kaki, Takahiro, Takase, Eri, Tanaka, Masanori, Harutani, Yuhei, Yamagata, Nao, Okuda, Yuka, Furuta, Katsuyuki, Sugimoto, Takeya, Teraoka, Shunsuke, Hayata, Atsushi, Tokudome, Nahomi, Ozawa, Yuichi, Mori, Keita, Koh, Yasuhiro, Yamamoto, Nobuyuki
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Immuno‐Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7160399/
https://ncbi.nlm.nih.gov/pubmed/32297443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0299
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados